文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
Marcia S. Brose
发表
1913O Results from the registrational phase I/II ARROW trial of pralsetinib (BLU-667) in patients (pts) with advanced RET mutation-positive medullary thyroid cancer (RET+ MTC)
A. Mansfield, G. Curigliano, M. Brose, 2020 .